DEBBIE FELICIANO: Open Payments
NPI 1710064761 · GLEN COVE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 25 payments from 11 companies in 2025. Trend: 2023 $777 · 2024 $467 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| ABBVIE INC. | 4 | $106 |
| Novo Nordisk Inc | 3 | $76 |
| Exact Sciences Corporation | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Indivior Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Amgen Inc. | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
Products named: AIRSUPRA, VRAYLAR, Cologuard Collection Kit, CAPLYTA, SUBLOCADE, GARDASIL 9, OTEZLA, Wegovy.
Industry payments across NY — which companies pay providers there.
